ELABORATION OF GUIDELINE FOR MONITORING IN RELATIVE BIOAVAILABILITY / PHARMACEUTICAL BIOEQUIVALENCE STUDY BY THE SPONSOR

Autor: Paula Thais Gozzi, Fernanda Giacomini Bueno, Patrícia Moura da Rosa Zimmermann, Liberato Brum Junior

Publikováno v: Arquivos de Ciências da Saúde da UNIPAR. 26

For registration of generic and similar drugs, it is necessary to carry out pharmaceutical equivalence (PE) tests and pharmaceutical bioequivalence (PB). To carry out these tests, duly qualified research centers are contracted, which need to be monit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a754f488443158072c0f7fac99932b83
https://doi.org/10.25110/arqsaude.v26i3.2022.8400

Effect of two oral formulations of cannabidiol on responses to emotional stimuli in healthy human volunteers: pharmaceutical vehicle matters

Autor: Regina Helena Costa Queiroz, Liberato Brum Junior, Patrícia Moura da Rosa Zimmermann, Isabella K. R. Dias, José Alexandre de Souza Crippa, Jaime Eduardo Cecílio Hallak, Francisco Silveira Guimarães, Lívia C. Pereira, Letícia Mello Rechia, Antonio Waldo Zuardi, Alline C. Campos, Luiz C. Pereira Junior

Publikováno v: Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Brazilian Journal of Psychiatry v.44 n.1 2022
Brazilian Journal of Psychiatry (São Paulo. 1999. Online)
Associação Brasileira de Psiquiatria (ABP)
instacron:ABP
Brazilian Journal of Psychiatry, Volume: 44, Issue: 1, Pages: 15-20, Published: 28 MAY 2021
Brazilian Journal of Psychiatry (2021)
Brazilian Journal of Psychiatry, Issue: ahead, Published: 28 MAY 2021

Objective: To compare plasma concentrations of cannabidiol (CBD) following oral administration of two formulations of the drug (powder and dissolved in oil), and to evaluate the effects of these distinct formulations on responses to emotional stimuli

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8426b8ad9df5f76272fef23c83ae2875
https://pubmed.ncbi.nlm.nih.gov/34076067

Biological bases for a possible effect of cannabidiol in Parkinson’s disease

Autor: Nilson C. Ferreira-Junior, Liberato Brum Junior, Jaime Eduardo Cecílio Hallak, Patrícia Moura da Rosa Zimmermann, José Alexandre de Souza Crippa, Francisco Silveira Guimarães, Alline C. Campos, Antonio Waldo Zuardi, Elaine Del-Bel

Publikováno v: Brazilian Journal of Psychiatry, Issue: ahead, Published: 15 JUL 2019
Brazilian Journal of Psychiatry
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Brazilian Journal of Psychiatry v.42 n.2 2020
Brazilian Journal of Psychiatry (São Paulo. 1999. Online)
Associação Brasileira de Psiquiatria (ABP)
instacron:ABP

Objective: Current pharmacotherapy of Parkinson’s disease (PD) is palliative and unable to modify the progression of neurodegeneration. Treatments that can improve patients’ quality of life with fewer side effects are needed, but not yet availabl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c7de69e7cc255470031f46c40a4a66b
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462019005012104&lng=en&tlng=en